Aripiprazole: A new risk factor for pathological gambling? A report of 8 case reports

Addictive Behaviors

Volumn 39, Issue 3, 2014, Pages 562-565

  Gaboriau, L ^a   Victorri Vigneau, C ^a,b   Gerardin M ^a,b   Allain Veyrac, G ^a   Jolliet Evin, P ^a,b   Grall Bronnec, M ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Universite de Nantes   (France)

Author keywords

Adverse drug reaction; Aripiprazole; Causality; Dopamine partial agonist; Pathological gambling

Indexed keywords

ARIPIPRAZOLE; QUETIAPINE;

ADDICTION; ADULT; ALCOHOL ABUSE; ALGORITHM; ARTICLE; BIPOLAR DISORDER; CANNABIS ADDICTION; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FAMILY CONFLICT; FAMILY HISTORY; FEMALE; FINANCIAL DEFICIT; GAMBLING; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; PARANOID SCHIZOPHRENIA; PATHOLOGICAL GAMBLING; PRESCRIPTION; PSYCHOSIS; PSYCHOTHERAPY; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SOCIAL ISOLATION; SUBSTANCE ABUSE; SUICIDAL IDEATION; TOBACCO DEPENDENCE; TREATMENT DURATION; YOUNG ADULT;

ADVERSE DRUG REACTION; ARIPIPRAZOLE; CAUSALITY; DOPAMINE PARTIAL AGONIST; PATHOLOGICAL GAMBLING;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DOPAMINE AGONISTS; FEMALE; GAMBLING; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; QUINOLONES; RISK FACTORS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84891661503     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2013.11.005     Document Type: Article

References (12)

1. Ahlskog J.E. Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease. Physiology and Behavior 2011, 104:168-172.
2. APA Diagnostic and statistical manual of mental disorders 1994, (Washington DC, USA). 4th ed.
3. Blaszczynski A., Nower L. A pathways model of problem and pathological gambling. Addiction 2002, 97(5):487-499.
4. Cohen J., Magalon D., Boyer L., Simon N., Christophe L. Aripiprazole-induced pathological gambling: a report of 3 cases. Current Drug Safety 2011, 6(1):51-53.
5. Currie S.R., Hodgins D.C., Wang J., el-Guebaly N., Wynne H., Chen S. Risk of harm among gamblers in the general population as a function of level of participation in gambling activities. Addiction 2006, 101(4):570-580.
6. Gavaudan G., Magalon D., Cohen J., Lancon C., Leonetti G., Pelissier-Alicot A.L. Partial agonist therapy in schizophrenia: relevance to diminished criminal responsibility. Journal of Forensic Sciences 2010, 55(6):1659-1662.
7. Kessler R.C., Hwang I., LaBrie R., Petukhova M., Sampson N.A., Winters K.C., et al. DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychological Medicine 2008, 38(9):1351-1360.
8. Naranjo C.A., Busto U., Sellers E.M., Sandor P., Ruiz I., Roberts E.A., et al. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics 1981, 30(2):239-245.
9. Rang H.P., Dale M.M., Ritter J.M., Flower R.J., Henderson G. Rang & Dale's pharmacology 2012, Elsevier Churchill Livingstone. 7th ed.
10. Roxanas M.G. Pathological gambling and compulsive eating associated with aripiprazole. The Australian and New Zealand Journal of Psychiatry 2010, 44(3):291.
11. Smith N., Kitchenham N., Bowden-Jones H. Pathological gambling and the treatment of psychosis with aripiprazole: Case reports. British Journal of Psychiatry 2011, 199(2):158-159.
12. Stahl S.M. Stahl's essential psychopharmacology. Neuroscientific basis and practical applications 2008, Cambridge University Press, New York.